Author:
Edition: 1
Publisher: Nova Biomedical Books
Binding: Hardcover
ISBN: 1607417081
Tumor Necrosis Factor (Cell Biology Research Progress)
Tumour Necrosis Factor (TNF) is a member of a superfamily of proteins, each with 157 amino acids, which induce necrosis (death) of tumour cells and possess a wide range of proinflammatory actions. Medical books Tumor Necrosis Factor . Tumour necrosis factor is a multifunctional cytokine with effects on lipid metabolism, coagulation, insulin resistance, and the function of endothelial cells lining blood vessels. Blocking the action of TNF has been shown to be beneficial in reducing the inflammation in inflammatory diseases such as Crohn's disease and rheumatoid arthritis. Inappropriate production of TNF or sustained activation of TNF signalling has been implicated in the pathogenesis of a wide spectrum of human diseases that include cancer, osteoporosis, sepsis, diabetes, and auto-immune diseases such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease. Extensive research within the last two decades has shown that TNF can be a potential therapeutic agent in various diseases Medical books Tumor Necrosis Factor: Methods and Protocols. Categories: Tumor necrosis factor, Disease models, Animal, Tumor necrosis facto. Contributors: Angelo Corti - Editor. Format: Paperback
Download link for Tumor Necrosis Factor: Methods and Protocols
Categories: Tumor necrosis factor, Disease models, Animal, Tumor necrosis facto. Contributors: Angelo Corti - Editor. Format: Paperback
Categories: Disease models, Animal, Tumor necrosis factor->Laboratory manuals. Contributors: Angelo Corti - Author. Format: Hardcover
Description: Clone TN3-19.12, IgG, Low Endotoxin Functional Formulation | Denotation: Tumor Necrosis Factor-alpha (TNF-a), Mouse | Synonyms: Leinco, TNF-a | Research area: Primary/Secondary Antibodies | Host: HaA | Order no.: T258-500
Human B cell activation factorr from the tumor necrosis factor family receptor,BAFF-R ELISA Kit
Medical Book Tumor Necrosis Factor
Tumour necrosis factor is a multifunctional cytokine with effects on lipid metabolism, coagulation, insulin resistance, and the function of endothelial cells lining blood vessels. Blocking the action of TNF has been shown to be beneficial in reducing the inflammation in inflammatory diseases such as Crohn's disease and rheumatoid arthritis. Inappropriate production of TNF or sustained activation of TNF signalling has been implicated in the pathogenesis of a wide spectrum of human diseases that include cancer, osteoporosis, sepsis, diabetes, and auto-immune diseases such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease. Extensive research within the last two decades has shown that TNF can be a potential therapeutic agent in various diseases. This new important book gathers the latest research from around the globe in this field.
